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The Ranvier nodes of thick myelinated nerve fibers contain almost exclusively voltage-gated sodium
channels (Navs), while the unmyelinated fibers have several receptors (e.g., cannabinoid, transient re-
ceptor potential vanilloid receptor 1), too. Therefore, a nerve which contains only motor fibers can be an
appropriate in vivo model for selective influence of Navs. The goals were to evaluate the potency of local
anesthetic drugs on such a nerve in vivo; furthermore, to investigate the effects of ligands with different
structures (arachidonic acid, anandamide, capsaicin and nisoxetine) that were proved to inhibit Navs in
vitro with antinociceptive properties.
The marginal mandibular branch of the facial nerve was explored in anesthetized Wistar rats; after its
stimulation, the electrical activity of the vibrissae muscles was registered following the perineural in-
jection of different drugs.
Lidocaine, bupivacaine and ropivacaine evoked dose-dependent decrease in electromyographic ac-
tivity, i.e., lidocaine had lower potency than bupivacaine or ropivacaine. QX-314 did not cause any effect
by itself, but its co-application with lidocaine produced a prolonged inhibition. Nisoxetine had a very low
potency. While anandamide and capsaicin in high doses caused about 50% decrease in the amplitude of
action potential, arachidonic acid did not influence the responses.
We proved that the classical local anesthetics have high potency on motor nerves, suggesting that this
method might be a reliable model for selective targeting of Navs in vivo circumstances. It is proposed
that the effects of these endogenous lipids and capsaicin on sensory fibers are not primarily mediated by
Navs.
& 2015 Elsevier B.V. All rights reserved.1. Introduction
The nodes of Ranvier of myelinated axons have voltage-gated
sodium channels (Navs) with high density to produce saltatory
conduction (Bucher and Goaillard, 2011; Salzer, 2002). In vitro data
have proved that besides the classic local anesthetic drugs, severalide (arachidonoyl ethanola-
eptor potential vanilloid 1;
ged.hu (A. Safrany-Fark),
d.u-szeged.hu (P. Liszli),ligands with different structures (such as arachidonic acid: AA,
anandamide: AEA, capsaicin or nisoxetine) can inhibit Navs, but no
in vivo data are available in this respect (Hennings et al., 1999;
Lundbaek et al., 2005; Nicholson et al., 2003). Capsaicin is a potent
activator of transient receptor potential vanilloid receptor 1
(TRPV1), while AEA activates both the cannabinoid and TRPV1
receptors (Di Marzo et al., 2000; Mechoulam et al., 1995). These
receptors can be found in sensory fibers but not in motor ones;
therefore, the effects of these ligands on sensory neurons may be
the sum of the changes in the activity of these different systems
(Petsche et al., 1983; Weller et al., 2011). Nisoxetine, a nor-
epinephrine reuptake inhibitor, has a local anesthetic effect, which
might be related to its Nav blocking effect (Chen et al., 2012; Yo-
kogawa et al., 2002). When the ligands are applied on mixed
nerves, it cannot be excluded that the motor responses were in-
fluenced by actions on sensory fibers, at least indirectly, through
A. Safrany-Fark et al. / European Journal of Pharmacology 762 (2015) 158–164 159reflex arches. These ligands can also inhibit voltage-gated po-
tassium channels with very low potencies (Boland and Drzewiecki,
2008; Borchard and Drouin, 1980; Dubois, 1982). Since these
channels are required for the repolarization, their inhibition en-
hances the excitability of the nerves (Krishnan et al., 2009; Mat-
sumoto et al., 2010). Thus, a nerve having only myelinated motor
fibers (e.g., marginal mandibular branch of the facial nerve, which
controls the movement of mystacial vibrissae) can be an appro-
priate model for selective influence of Navs in vivo circumstances
(Fundin et al., 1994; Semba and Egger, 1986). Tertiary amine local
anesthetics block action potentials by inhibiting Navs from inside
the nerve membrane (Butterworth and Strichartz, 1990; Frazier
et al., 1970). The hydrophilic lidocaine derivative, QX-314, is in-
capable of diffusion through the membrane lipids in myelinated
nerve fibers (Strichartz, 1973), but it can enter into the cytoplasm
through activated TRPV1 channels leading to the preferential block
of Navs in nociceptive fibers (Binshtok et al., 2007; Lim et al.,
2007). Furthermore, QX-314 can enhance the efficacy of local an-
esthetics on sensory and motor functions applied to the mixed,
perisciatic nerve (Binshtok et al., 2009; Roberson et al., 2011).
Our hypothesis was that if the local anesthetic drugs inhibit the
signal conduction in the marginal mandibular branch of the facial
nerve, this in vivo model can be used to characterize the Navs
blocking potency of different ligands. The first goal was to set up
and validate the model by three classical local anesthetics: lido-
caine, bupivacaine and ropivacaine. It was also planned to in-
vestigate the potency of QX-314 alone and in combination with
lidocaine; hereafter, to determine the effects of AA, AEA, capsaicin,
and nisoxetine in order to reveal the potential role of Navs in their
antinociceptive properties after perineural administration.2. Material and methods
All experiments were carried out with the approval of the
Hungarian Ethical Committee for Animal Research (Registration
number: XIV/3754/2012). Wistar rats were anesthetized with an
intraperitoneally injected mixture of ketamine (72 mg/kg) and
xylazine (8 mg/kg), and facial area was shaved. The marginal
mandibular branch of the facial nerve was explored at buccal level,
and it was wrapped around with a unipolar wire electrode
(0.1 mm) for electrical stimulation to induce the whisker move-
ment. The ground electrode was placed close to the nerve and
muscle. The stimulations with rectangular biphasic pulses of
constant current were delivered through a stimulator with a su-
pramaximal stimulus (1 mA for 250 ms). Electromyograph (EMG)
activities after a single stimulus were recorded with unipolar
needle electrodes placed into the whisker area of the rats. EMG
recordings were amplified (Model 1700 Differential AC Amplifier,
A-M Systems, Carlsborg WA), sampled at 20 kHz with an A/D
board, filtered (100 Hz to 5 kHz), and stored on a computer run-
ning software. The maximal amplitude was determined as a dif-
ference between the highest positive and lowest negative peak of
the compound action potential. Amplitudes and peak-latencies (if
there were any) were analyzed.
2.1. Drugs
The following drugs were administered: lidocaine (MW:
234.33; Lidocaine; Egis Pharmaceuticals PLC, Budapest, Hungary),
bupivacaine (MW: 288.43; Actavis, Weston, Florida, USA), ropiva-
caine (MW: 274.40; Naropin, AstraZeneca, London, United King-
dom), anandamide (AEA; MW: 347.53), arachidonic acid (AA; MW:
304.47), QX-314 (MW: 263.40), all three from Sigma-Aldrich, Bu-
dapest, Hungary, nisoxetine hydrochloride (MW: 307.82; Tocris,
Budapest, Hungary) and capsaicin (MW: 305.40; Plantakem Kft.,Sándorfalva, Hungary). AA was dissolved in 10% ethanol, AEA was
dissolved in 10% ethanolþ4% Tween 80, and capsaicin in 10%
ethanolþ10% Tween 80. QX-314 was dissolved in phosphate buf-
fered saline (at pH¼7.4) (Liu et al., 2011). All the stock solutions
were further diluted with saline.
2.2. Experimental protocol
After 3 consecutive determinations of EMG activities (baseline)
with 2 min intervals, the effects of the different ligands were in-
vestigated. Drugs were administered perineurally distal to the
stimulating electrode in 20 mL volume. The applied doses were
21.4, 85.5, 213.7 nmol (5, 20, 50 mg) for lidocaine; 17.3, 69.3,
173.4 nmol (5, 20, 50 mg) for bupivacaine; 18.2, 72.9, 182.2 nmol (5,
20, 50 mg) for ropivacaine; 184.3, 368.5, 737.0 nmol (50, 100,
200 mg) for nisoxetine; 328.4, 656.8, 1313.6 nmol (100, 200,
400 mg) for AA; 72, 288, 576, 1152 nmol (25, 100, 200, 400 mg) for
AEA; 331.5, 663, 1326 nmol (125, 250, 500 mg) for capsaicin. As
regard QX-314, one high dose (100 mg¼380 nmol) was used by
itself. Because of the solubility of QX-314 in the applied volume,
190 nmol (50 mg) was applied together with 21.4 nmol (5 mg) or
85.5 nmol (20 mg) lidocaine in combinations.
The measurements were repeated 30, 60, 90, 120 s after the
administration, and then in 2 min intervals for 30 min in total. The
mean values between 0.5–2, 4–10, 12–20 and 22–30 min intervals
were analyzed as 1st, 2nd, 3rd and 4th time periods. The number
of animals in the different groups was 6–10.
2.3. Statistical analysis
Data are presented as means7S.E.M. Amplitudes of EMG ac-
tivity were normalized by calculating the percentage change from
baseline (mean of the 3 baseline values) for each post-injection
data point by the following formula:
Relative amplitude of EMG activity (%)¼(observed amplitude/
baseline amplitude)100.
Therefore, 100% means no effect of the drug on the amplitude
of EMG activity, while 0% means that there is no EMG response
after the stimulus.
The area under the curve (AUC) values were obtained by cal-
culating the area during the 30 min period following the injection
to construct dose response curves for the different ligands. AUCmin
(0) value would mean the complete disappearance of EMG re-
sponses, while AUCmax (2800) would mean the 100% value of the
amplitudes of action potentials (no drug effect). The mean AUC
values were used for linear regression analysis (least square
method) to determine the effective dose 50 (ED50) values with 95%
confidence intervals, which is equivalent to the dose that yielded
50% decrease in the amplitude of action potentials for the whole
period ([AUCminþAUCmax]/2¼1400).
The time-course effects were examined by repeated measure-
ment of ANOVA. The post-hoc comparison was calculated by using
the Newmann–Keuls test (P value o0.05 was considered sig-
nificant). Statistical analyses were performed with STATISTICA for
Windows version 12 (Statistica, Inc., Tulsa, Oklahoma, USA) and
GraphPad Prism (GraphPad Software, Inc., La Jolla, California, USA)
softwares.3. Results
Marginal mandibular motor nerve stimulations produced EMG
activity with visible whisker movements. The latency and the
amplitude of EMG responses were stable during the investigated
period in the vehicle treated groups (Fig. 1A). The latency of the
first positive peak appeared at 1.970.02 ms, while the second
Fig. 1. Electromyography (EMG) activities after vehicle or local anesthetic drug application. EMG activity after the application of different vehicles (A). Time response effects
of different doses of lidocaine (B), bupivacaine (C), or ropivacaine (D) on EMG activity. Each curve represents the mean7S.E.M. of relative amplitude of EMG activity (%). The
1st, 2nd, 3rd and 4th time periods refer to the time intervals between 0.5–2, 4–10, 12–20 and 22–30 min. *Po0.05 compared with the saline-treated group using Newmann–
Keuls post-hoc test, following significant results of repeated measurement of ANOVA.
Fig. 2. Area under the curve (AUC) values of local anesthetic drugs. Linear
regression curves of AUC values for lidocaine, bupivacaine, ropivacaine and
nisoxetine. Each line represents the mean7S.E.M. of AUC values.
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2.870.1 mV. The analysis of the peak latencies (if any response
was detected) did not reveal significant effects of any drug, i.e.,
peak latencies were not influenced significantly by any treatment
(data are not shown); thus, only the amplitude changes were
analyzed.
Regarding the effects of lidocaine, significant effects of doses
(F3,37¼33.6; Po0.001) and time (F3,111¼8.3; Po0.001) were ob-
served (Fig. 1B). ANOVA also showed significant effects of doses
(F3,28¼17.0, Po0.001), time (F3,84¼20.8; Po0.001) and interaction
(F9,84¼10.0; Po0.001) in case of bupivacaine administrations
(Fig. 1C). Similarly, in case of ropivacaine administrations ANOVA
also showed significant effects of doses (F3,27¼24.3, Po0.001),
time (F3,81¼9.8; Po0.001) and interaction (F9,81¼9.0; Po0.001)
(Fig. 1D). All of these drugs produced prolonged EMG depression in
higher doses. The linear regression curves of AUC data showed
slight potency differences among these local anesthetic drugs
(Fig. 2); thus, the ED50 value was the highest for lidocaine [75.9 (CI:
61.0–93.3) nmol], while bupivacaine [34.7 (CI: 21.1–58.1) nmol] and
ropivacaine [36.3 (CI: 23.0–72.3) nmol] had slightly higher potency.
Regarding the effect of QX-314 (380 nmol) by itself, it did not
produce any effect on EMG activity (data are not shown); however, co-
administration of 190 nmol QX-314 potentiated and prolonged the
effects of lidocaine administrated in 21.4 and 85.5 nmol doses (Fig. 3A
and B). ANOVA showed significant effects of interaction (F3,75¼7.03;
Po0.001) in case of the lower dose combination, while treatment was
close to significant (P¼0.051). ANOVA showed significant effects of
time (F3,51¼6.6; Po0.001) and interaction (F3,51¼4.3; Po0.01) in caseof the higher dose combination.
Regarding nisoxetine treatment, ANOVA showed significant
effects of doses (F3,30¼3.5, Po0.05), time (F3,90¼12.0; Po0.001)
and interaction (F9,90¼4.6; Po0.001) (Fig. 4). The linear regres-
sion curves of AUC data showed that nisoxetine had very low
potency [ED50: 580.7 (CI: 206.5–1633.1) nmol] compared to the
classical local anesthetic drugs (Fig. 2).
Regarding the effects of AA, it did not produce significant in-
hibition on the evoked action potentials even in high doses
(Fig. 5A). ANOVA showed significant effects of doses (F4,28¼2.7,
Po0.05) after AEA application; thus, 567 nmol produced about
50% inhibitory tendency, but the post-hoc analysis did not show
Fig. 3. Electromyography (EMG) activities after lidocaine and QX-314 application. EMG activity after lidocaine application in low (21.4 nmol) (A) or high (85.5 nmol) (B) dose
alone and coadministered with QX-314. Each curve represents the mean7S.E.M. of relative amplitude of EMG activity (%). The 1st, 2nd, 3rd and 4th time periods refer to the
time intervals between 0.5–2, 4–10, 12–20 and 22–30 min. *Po0.05 compared with the lidocaine-treated group using Newmann–Keuls post-hoc test, following significant
results of repeated measurement of ANOVA.
Fig. 4. Electromyography (EMG) activities after nisoxetine application. The time–
response effect of different doses of nisoxetine on EMG activity. Each curve re-
presents the mean7S.E.M. of relative amplitude of EMG activity (%). The 1st, 2nd,
3rd and 4th time periods refer to the time intervals between 0.5–2, 4–10, 12–20
and 22–30 min. *Po0.05 compared with the saline-treated group using New-
mann–Keuls post-hoc test, following significant results of repeated measurement
of ANOVA.
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points (Fig. 5B). In case of capsaicin treatment, ANOVA showed
significant effects of doses (F3,25¼4.4, Po0.05), time (F3,75¼4.7;
Po0.005) and interaction (F9,75¼4.5; Po0.001); thus, 663 nmol
produced about 50% inhibition, and the post-hoc analysis showed
significant differences between the vehicle and capsaicin appli-
cation in the latest time period (Fig. 5C). The linear regression
analysis did not show significant dose response for these ligands;
therefore, ED50 values could not be calculated.4. Discussion
Our data demonstrated that perineural injection of classical
local anesthetic ligands has high potency on nerves containing
only motor fibers, suggesting that our model might be a reliable
and simple test to investigate the in vivo effects of different mo-
lecules via primarily on Navs. Furthermore, nisoxetine had very
small efficacy in this model, and QX-314 did not produce any effect
on motor fiber function by itself, but it slightly potentiated the
effect of lidocaine in agreement with earlier behavioral studies
(Binshtok et al., 2009; Brenneis et al., 2014). Our data first revealedthe in vivo effects of two unsaturated lipid derivatives on EMG
activity of motor fibers. AA was ineffective, while AEA and cap-
saicin had a modest blocking effect in high but not in the maximal
applied dose suggesting that they do not have significant effects
on Navs in vivo circumstances in moderate doses.
It is well-known that the myelin sheath is periodically inter-
rupted by the nodes of Ranvier, regions with a high density of
Navs, which generate the spike, and they mediate fast saltatory
conduction (Salzer, 2002). Local anesthetics are drugs that produce
reversible inhibition of nerve conduction acting on Nav in different
types of nerve fibers (Butterworth and Strichartz, 1990). Presently,
the local anesthetics in clinical use are mainly tertiary amines, and
these drugs, under physiological conditions, exist in a mixture of
protonated and neutral, uncharged forms (Butterworth and Ox-
ford, 2009; Frazier et al., 1970). The uncharged hydrophobic form
can penetrate through the lipid layers of the neuronal cell mem-
brane (Frazier et al., 1970). Once they gain access to the local an-
esthetic binding site on the cytoplasmic side of the conducting
pore of Navs, the protonated form appears to be more potent than
the neutral one.
Lidocaine [2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide],
bupivacaine [(RS)1-butyl-N-(2,6-dimethylphenyl)piperidine-2-car-
boxamide] and ropivacaine [(S)-N-(2,6-dimethylphenyl)-1-pro-
pylpiperidine-2-carboxamide] are widely used local anesthetic
drugs (Nakagawa and Hiura, 2013). We found slight potency dif-
ferences between these drugs; i.e., bupivacaine and ropivacaine had
almost the same potency on EMG activity, and this was slightly
higher compared to lidocaine (Sisk, 1992). These results are in
agreement with data on human subjects, and partially, with their
lipid solubility; i.e., the octanol/buffer partition coefficient of lido-
caine is the lowest, which might lead to its lower potency (Stri-
chartz et al., 1990). Since other class 1 antiarrhythmic drugs such as
quinidine also inhibited the evoked compound muscle action po-
tentials, we suppose that our model might be capable to display
some intermediate degree of actions mediated by Navs (Cheng et al.,
2014).
As it was mentioned in the Introduction, QX-314 can produce
selective inactivation of Navs in sensory neurons by entering the
cells through TRP channels; therefore, its topical administration
alone does not influence the motor functions (Binshtok et al.,
2007, 2009; Kim et al., 2010; Shen et al., 2012). However, its
perisciatic application in very high doses can produce temporary
motor impairments (Lim et al., 2007; Roberson et al., 2011). Until
now only one study has recorded the EMG activity from the di-
gastric muscle to painful stimuli of the dental cavity after QX-314
Fig. 5. Electromyography (EMG) activities after endogenous lipids and capsaicin application. The time–response effect of different doses of arachidonic acid ([AA], A),
anandamide ([AEA], B) or capsaicin (C) on EMG activity. Each curve represents the mean7S.E.M. of relative amplitude of EMG activity (%). The 1st, 2nd, 3rd and 4th time
periods refer to the time intervals between 0.5–2, 4–10, 12–20 and 22–30 min. *Po0.05 compared with the vehicle-treated group using Newmann–Keuls post-hoc test,
following significant results of repeated measurement of ANOVA.
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nerve activity, which is perfectly agreement with our results (Kim
et al., 2010). Regarding the effects of QX-314 with bupivacaine or
lidocaine, a prolonged motor paralysis has been observed after
their perisciatic (mixed nerve) administrations (Binshtok et al.,
2009; Brenneis et al., 2014; Roberson et al., 2011) similarly to our
present results. Since QX-314 cannot influence the Nav extra-
cellularly, pharmacokinetic interaction between the two ligands
such as their binding to plasma proteins can modify the elimina-
tion of lidocaine (Taheri et al., 2003). Furthermore, it has been
recently shown that bupivacaine and lidocaine can cause QX-314
accumulation in cells which do not express TRPV1 or TRPA1
channels, and it also induces a prolonged block of C-fibers of iso-
lated sciatic nerves in TRPA1-TRPV1 double knockout mice
(Brenneis et al., 2014). Furthermore, the analgesia and motor block
produced by the co-application of bupivacaine and QX-314 to rat
sciatic nerve is not abolished by ruthenium red (TRP channel
blocker). It is suggested that the mechanism of this potentiation is
most likely relies on the interaction of the local anesthetics and
the lipid bilayer itself (Brenneis et al., 2014), but further experi-
ments are required to reveal the exact mechanism of their
interaction.
Some data show that nisoxetine, [(RS)-3-(2-methoxyphenoxy)-
N-methyl-3-phenylpropan-1-amine], inhibits Navs in vitro models
and also produces dose dependent blockade during spinal an-
esthesia in rats (Hennings et al., 1999; Leung et al., 2013). Chen
et al. (2012) have compared the local anesthetic effect of nisox-
etine with lidocaine in the cutaneous trunci muscle reflex, and
nisoxetine had high inhibitory potency, suggesting that both drugsinhibit Navs on sensory axons. In contrast to these findings, we
found very low potency of nisoxetine on motor fibers, which is in
agreement with the in vitro results (Hennings et al., 1999; Leung
et al., 2013). The controversy might be due to the differences in the
applied model as the earlier study investigated only the sensory
functions (Chen et al., 2012). It might be supposed that the
structural differences between the motor and sensory fibers could
result in decreased potency in motor fibers, which might be ben-
eficial in clinical circumstances (Krishnan et al., 2009).
Functional studies suggest that TRPV1 and cannabinoid receptors
are expressed peripherally on (primarily unmyelinated) sensory fi-
bers (Bernardini et al., 2004; Domoki et al., 2003; Gamse et al., 1982;
Sann et al., 1995; Santha and Jancso, 2003; Sauer and Reeh, 2009;
Tominaga et al., 1998). Therefore, perineural capsaicin and AEA can
influence the activity of these fibers by acting on these receptors.
There is no proof about the presence of TRPV1 or cannabinoid re-
ceptors on motor fibers, and perineural application of capsaicin does
not influence the activity of myelinated fibers (Brenneis et al., 2013;
Petsche et al., 1983; Weller et al., 2011). Since most of the peripheral
nerves (e.g., the sciatic nerve) contain both sensory and motor fibers,
it would be difficult to distinguish between the effects on TRPV1/
cannabinoid CB1 receptors and Navs. As earlier in vitro results
showed, AA and AEA can inhibit Nav in high doses by a hyperpo-
larizing shift of the steady-state inactivation voltage independently of
cannabinoid receptor activations (Al Kury et al., 2014; Boland and
Drzewiecki, 2008; Fang et al., 2011; Lee et al., 2002; Nicholson et al.,
2003). It was also suggested that AEA-induced antinociception in
cannabinoid CB1 receptor knockout mice might have been due to the
state-dependent inhibition of sodium currents in sensory neurons
A. Safrany-Fark et al. / European Journal of Pharmacology 762 (2015) 158–164 163(Di Marzo et al., 2000). In vitro studies have presented that capsaicin
also inhibits Navs at a high concentration (410 mM) (Abel et al.,
2003; Cao et al., 2007; Duan et al., 2007; Lundbaek et al., 2005; Ni-
cholson et al., 2003; Wang et al., 2007; Yamanaka et al., 1984). These
effects could be observed in TRPV1 knockout mice and TRPV1 an-
tagonist independent manner, even the TRPV1 receptor antagonist,
capsazepine, causes similar effects as capsaicin (Cao et al., 2007;
Lundbaek et al., 2005; Wang et al., 2007). Since our model in-
vestigates a nerve containing only motor fibers, it can be an appro-
priate model for examining primarily Navs-mediated effects (Fundin
et al., 1994; Semba and Egger, 1986). In contrast to the in vitro results,
our in vivo data showed that AA could not produce any effect on the
motor nerve activity, which might be due to its low potency and/or
fast metabolism. Both AEA and capsaicin caused slight inhibition on
EMG activity in high doses (capsaicin: 663 nmol; AEA: 576 nmol), but
their largest applied doses (capsaicin: 1326 nmol; AEA: 1152 nmol)
were ineffective. We cannot give an explanation for this phenom-
enon, but these highly lipophylic ligands could alter the lipid bilayer
elasticity; thus, a stiffening of the membrane can cause conforma-
tional changes in the channel proteins leading to alteration in the
function of Navs at special doses (Duan et al., 2007, 2008; Jiang and
Gonen, 2012; Lundbaek et al., 2005).
Since these effective doses were very high, their pharmacolo-
gical utilization is questionable.Since local anesthetic drugs, lipids
and capsaicin can also inhibit voltage-gated potassium channels,
located primarily paranodally, with very low potencies, it cannot
be excluded that the inhibition of these channels might partially
mask Navs-mediated effects (Boland and Drzewiecki, 2008;
Borchard and Drouin, 1980; Dubois, 1982; Evans et al., 2008; Jiang
and Gonen, 2012; Krishnan et al., 2009; Kuenzi and Dale, 1996;
Matsumoto et al., 2010). In conclusion, we demonstrated that our
in vivo model is an appropriate and reproducible interdisciplinary
test to investigate the Nav-mediated effects of different molecules.
In vivo models offer certain advantages over in vitro studies since
they might have more relevance to clinical conditions. The in-
efficiency or very low potency of lipids and capsaicin on motor
fibers suggests that the observed effects on peripheral neurons in
lower doses might not be due to the effects on Navs.Acknowledgment
This work was supported by the Hungarian Scientific Research
Fund (OTKA, K83810) and TÁMOP-4.2.2.A-11/1KONV-2012-0052.
The authors wish to thank Agnes Tandari for her excellent tech-
nical assistance. The authors declare no competing financial
interests.References
Abel, K.M., Allin, M.P., Hemsley, D.R., Geyer, M.A., 2003. Low dose ketamine in-
creases prepulse inhibition in healthy men. Neuropharmacology 44, 729–737.
Al Kury, L.T., Vojtechova, O.I., Yang, K.H., Thayyullathil, F.T., Doroshenko, P., Ramirez,
A.M., Shuba, Y.M., Galadari, S., Howarth, F.C., Oz, M., 2014. Effects of the en-
dogenous cannabinoid anandamide on voltage-dependent sodium and calcium
channels in rat ventricular myocytes. Br. J. Pharmacol. 171, 3485–3498.
Bernardini, N., Neuhuber, W., Reeh, P.W., Sauer, S.K., 2004. Morphological evidence
for functional capsaicin receptor expression and calcitonin gene-related pep-
tide exocytosis in isolated peripheral nerve axons of the mouse. Neuroscience
126, 585–590.
Binshtok, A.M., Bean, B.P., Woolf, C.J., 2007. Inhibiton of nociceptors by TRPV1-
mediated entry of impermeant sodium channel blockers. Nature 449, 607–611.
Binshtok, A.M., Gerner, P., Oh, S.B., Puopolo, M., Suzuki, S., Roberson, D.P., Herbert,
T., Wang, C.F., Kim, D., Chung, G., Mitani, A.A., Wang, G.K., Bean, B.P., Woolf, C.J.,
2009. Coapplication of lidocaine and the permanently charged sodium channel
blocker QX-314 produces a long-lasting nociceptive blockade in rodents. An-
esthesiology 111, 127–137.
Boland, L.M., Drzewiecki, M.M., 2008. Polyunsaturated fatty acid modulation of
voltage-gated ion channels. Cell Biochem. Biophys. 52, 59–84.Borchard, U., Drouin, H., 1980. Caricaine: action of the local anesthetic on myeli-
nated nerve fibres. Eur. J. Pharmacol. 62, 73–79.
Brenneis, C., Kistner, K., Puopolo, M., Jo, S., Roberson, D.P., Sisignano, M., Segal, D.,
Cobos, E.J., Wainger, B.J., Labocha, S., Ferreirþ-s, N., von Hehn, C., Tran, J.,
Geisslinger, G., Reeh, P.W., Bean, B.P., Woolf, C.J., 2014. Bupivacaine-induced
cellular entry of QX-314 and its contribution to differential nerve block. Br. J.
Pharmacol. 171, 438–451.
Brenneis, C., Kistner, K., Puopolo, M., Segal, D., Roberson, D., Sisignano, M., Labocha,
S., Ferreiros, N., Strominger, A., Cobos, E.J., Ghasemlou, N., Geisslinger, G., Reeh,
P.W., Bean, B.P., Woolf, C.J., 2013. Phenotyping the function of TRPV1-expressing
sensory neurons by targeted axonal silencing. J. Neurosci. 33, 315–326.
Bucher, D., Goaillard, J.M., 2011. Beyond faithful conduction: short-term dynamics,
neuromodulation, and long-term regulation of spike propagation in the axon.
Prog. Neurobiol. 94, 307–346.
Butterworth, J., Oxford, G.S., 2009. Local anesthetics: a new hydrophilic pathway for
the drug-receptor reaction. Anesthesiology 111, 12–14.
Butterworth, J.F., Strichartz, G.R., 1990. Molecular mechanisms of local anesthesia: a
review. Anesthesiology 72, 711–734.
Cao, X., Cao, X., Xie, H., Yang, R., Lei, G., Li, F., Li, A., Liu, C., Liu, L., 2007. Effects of
capsaicin on VGSCs in TRPV1/ mice. Brain Res. 1163, 33–43.
Chen, Y.W., Chu, C.C., Chen, Y.C., Wang, J.J., Hung, C.H., Shao, D.Z., 2012. Nisoxetine
produces local but not systemic analgesia against cutaneous nociveptive stimuli
in the rat. Eur. J. Pharmacol. 675, 22–25.
Cheng, K.I., Lin, I.L., Chang, L.L., Jou, I.M., Lai, C.S., Wang, J.J., Wang, H.C., Kwan, A.L.,
2014. Application of quinidine on rat sciatic nerve decreases the amplitude and
increases the latency of evoked responses. J. Anesth. 28, 559–568.
Di Marzo, V., Breivogel, C.S., Tao, Q., Bridgen, D.T., Razdan, R.K., Zimmer, A.M.,
Zimmer, A., Martin, B.R., 2000. Levels, metabolism, and pharmacological ac-
tivity of anandamide in CB1 cannabinoid receptor knockout mice. Evidence for
non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. J.
Neurochem. 75, 2434–2444.
Domoki, F., Santha, P., Bari, F., Jancso, G., 2003. Perineural capsaicin treatment at-
tenuates reactive hyperaemia in the rat skin. Neurosci. Lett. 341, 127–130.
Duan, Y., Zheng, J., Nicholson, R.A., 2007. Vanilloid (subtype 1) receptor-modulatory
drugs inhibit [3H]batrachotoxinin-A 20-alfa-benzoate binding to Naþ channels.
Basic Clin. Pharmacol. Toxicol. 100, 91–95.
Duan, Y., Zheng, J., Nicholson, R.A., 2008. Inhibition of [3H]batrachotoxinin
A-20alpha-benzoate binding to sodium channels and sodium channel function
by endocannabinoids. Neurochem. Int. 52, 438–446.
Dubois, J.M., 1982. Capsaicin blocks one class of Kþchannels in the frog node of
Ranvier. Brain Res. 245, 372–375.
Evans, R.M., Wease, K.N., MacDonald, C.J., Khairy, H.A., Ross, R.A., Scott, R.H., 2008.
Modulation of sensory neuron potassium conductances by anandamide in-
dicates roles for metabolites. Br. J. Pharmacol. 154 (2), 480–492.
Fang, Y.J., Zhou, M.H., Gao, X.F., Gu, H., Mei, Y.A., 2011. Arachidonic acid modulates
Naþ currents by non-metabolic and metabolic pathways in rat cerebellar
granule cells. Biochem. J. 438, 203–215.
Frazier, D.T., Narahashi, T., Yamada, M., 1970. The site of action and active form of
local anethetics. II. Experiments with quaternary compounds. J. Pharmacol. Exp.
Ther. 171, 45–51.
Fundin, B.T., Rice, F.L., Pfaller, K., Arvidsson, J., 1994. The innervation of the mys-
tacial pad in the adult-rat studied by anterograde transport of HRP conjugates.
Exp. Brain Res. 99, 233–246.
Gamse, R., Petsche, U., Lembeck, F., Jancso, G., 1982. Capsaicin applied to peripheral
nerve inhibits axoplasmic transport of substance P and somatostatin. Brain Res.
239, 447–462.
Hennings, E.C.P., Kiss, J.P., De Oliveira, K., Toth, P.T., Vizi, E.S., 1999. Nicotinic acet-
ylcholine receptor antagonistic activity of monoamine uptake blockers in rat
hippocampal slices. J. Neurochem. 73, 1043–1050.
Jiang, Q.X., Gonen, T., 2012. The influence of lipids on voltage-gated ion channels.
Curr. Opin. Struct. Biol. 22, 529–536.
Kim, H.Y., Kim, K., Li, H.Y., Chung, G., Park, C.K., Kim, J.S., Jung, S.J., Lee, M.K., Ahn, D.
K., Hwang, S.J., Kang, Y., Binshtok, A.M., Bean, B.P., Woolf, C.J., Oh, S.B., 2010.
Selectively targeting pain in the trigeminal system. Pain 150, 29–40.
Krishnan, A.V., Lin, C.S.Y., Park, S.B., Kiernan, M.C., 2009. Axonal ion channels from
bench to bedside: a translational neuroscience perspective. Prog. Neurobiol. 89,
288–313.
Kuenzi, F.M., Dale, N., 1996. Effect of capsaicin and analogues on potassium and
calcium currents and vanilloid receptors in xenopus embryo spinal neurones.
Br. J. Pharmacol. 119, 81–90.
Lee, G.Y., Shin, Y.K., Lee, C.S., Song, J.H., 2002. Effects of arachidonic acid on sodium
currents in rat dorsal root ganglion neurons. Brain Res. 950, 95–102.
Leung, Y.M., Chu, C.C., Kuo, C.S., Chen, Y.W., Wang, J.J., 2013. Nisoxetine blocks so-
dium currents and elicits spinal anesthesia in rats. Pharmacol. Rep. 65,
350–357.
Lim, T.K.Y., MacLeod, B.A., Ries, C.R., Schwarz, S.K.W., 2007. The quaternary lido-
caine derivative, QX-314, produces long-lasting local anesthesia in animal
models in vivo. Anesthesiology 107, 305–311.
Liu, H., Zhang, H.X., Hou, H.Y., Lu, X.F., Wei, J.Q., Wang, C.G., Zhang, L.C., Zeng, Y.M.,
Wu, Y.P., Cao, J.L., 2011. Acid solution is a suitable medium for introducing QX-
314 into nociceptors through TRPV1 channels to produce sensory-specific an-
algesic effects. PLoS One 6, e29395.
Lundbaek, J.A., Birn, P., Tape, S.E., Toombes, G.E.S., Sogaard, R., Koeppe II, R.E.,
Gruner, S.M., Hansen, A.J., Andersen, O.S., 2005. Capsaicin regulates voltage-
dependent sodium channels by altering lipid bilayer elasticity. Mol. Pharmacol.
68, 680–689.
A. Safrany-Fark et al. / European Journal of Pharmacology 762 (2015) 158–164164Mechoulam, R., Ben Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R.,
Gopher, A., Almog, S., Martin, B.R., Compton, 1995. Identification of an en-
dogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid
receptors. Biochem. Pharmacol. 50, 83–90.
Matsumoto, S., Yoshida, S., Takahashi, M., Saiki, C., Takeda, M., 2010. The roles of I
(D), I(A) and I(K) in the electrophysiological functions of small diameter rat
trigeminal ganglion neurons. Curr. Mol. Pharmacol. 3, 30–36.
Nakagawa, H., Hiura, A., 2013. Comparison of the transport of QX-314 through
TRPA1, TRPM8, and TRPV1 channels. J. Pain Res. 6, 223–230.
Nicholson, R.A., Liao, C., Zheng, J., David, L.S., Coyne, L., Errington, A.C., Singh, G.,
Lees, G., 2003. Sodium channel inhibition by anandamide and synthetic can-
nabimimetics in brain. Brain Res. 978, 194–204.
Petsche, U., Fleischer, E., Lembeck, F., Handwerker, H.O., 1983. The effect of cap-
saicin application to a peripheral nerve on impulse conduction in functionally
identified afferent nerve fibres. Brain Res. 265, 233–240.
Roberson, D.P., Binshtok, A.M., Blasl, F., Bean, B.P., Woolf, C.J., 2011. Targeting of
sodium channel blockers into nociceptors to produce long-duration analgesia:
a systematic study and review. Br. J. Pharmacol. 164, 48–58.
Salzer, J.L., 2002. Nodes of ranvier come of age. Trends Neurosci. 25, 2–5.
Sann, H., Jancso, G., Rossler, W., Pierau, F.K., 1995. Reduction of substance P binding
sites in the spinal dorsal horn after perineural capsaicin treatment in the rat.
Neurosci. Lett. 190, 151–154.
Santha, P., Jancso, G., 2003. Transganglionic transport of choleragenoid by capsai-
cin-sensitive C-fibre afferents to the substantia gelatinosa of the spinal dorsal
horn after peripheral nerve section. Neuroscience 116, 621–627.
Sauer, S.K., Reeh, P.W., 2009. Inflammation and hypersensitivity in the context of
the sensory functions of axonal membranes: what are the molecular me-
chanisms? Dig. Dis. 27 (Suppl. 1), S11–S15.
Semba, K., Egger, M.D., 1986. The facial “motor” nerve of the rat: control of vibrissal
movement and examination of motor and sensory components. J. Comp.Neurol. 247, 144–158.
Shen, J., Fox, L.E., Cheng, J.G., 2012. Differential effects of peripheral versus central
coadministration of QX-314 and capsaicin on neuropathic pain in rats. An-
esthesiology 117, 365–380.
Sisk, A.L., 1992. Long-acting local anesthetics in dentistry. Anesth. Prog. 39, 53–60.
Strichartz, G.R., 1973. The inhibition of sodium currents in myelinated nerve by
quaternary derivatives of lidocaine. J. Gen. Physiol. 62, 37–57.
Strichartz, G.R., Sanchez, V., Arthur, G.R., Chafetz, R., Martin, D., 1990. Fundamental
properties of local anesthetics. II. measured octanol: buffer partition coeffi-
cients and pKa values of clinically used drugs. Anesth. Analg. 71, 158–170.
Taheri, S., Cogswell, L.P., Gent, A., Strichartz, G.R., 2003. Hydrophobic and ionic
factors in the binding of local anesthetics to the major variant of human al-
pha1-acid glycoprotein. J. Pharmacol. Exp. Ther. 304, 71–80.
Tominaga, M., Caterina, M.J., Malmberg, A.B., Rosen, T.A., Gilbert, H., Skinner, K.,
Raumann, B.E., Basbaum, A.I., Julius, D., 1998. The cloned capsaicin receptor
integrates multiple pain-producing stimuli. Neuron 21, 531–543.
Wang, S.Y., Mitchell, J., Wang, G.K., 2007. Preferential block of inactivation-deficient
Naþ currents by capsaicin reveals a non-TRPV1 receptor within the Naþ
channel. Pain 127, 73–83.
Weller, K., Reeh, P.W., Sauer, S.K., 2011. TRPV1, TRPA1, and CB1 in the isolated vagus
nerve – axonal chemosensitivity and control of neuropeptide release. Neuro-
peptides 45, 391–400.
Yamanaka, K., Kigoshi, S., Muramatsu, I., 1984. Conduction-block induced by cap-
saicin in crayfish giant axon. Brain Res. 300, 113–119.
Yokogawa, F., Kiuchi, Y., Ishikaw, Y., Otsuka, N., Masuda, Y., Oguchi, K., Hosoyamada,
A., 2002. An investigation of monoamine receptors involved in antinociceptive
effects of antidepressants. Anesth. Analg. 95, 163–168.
